Opendata, web and dolomites

HemoScreen SIGNED

Point-of-care hematology analyser based on visco-elastic focusing, digital imaging, image processing and machine learning

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 HemoScreen project word cloud

Explore the words cloud of the HemoScreen project. It provides you a very rough idea of what is the project "HemoScreen" about.

industrialization    headcount    feedback    first    usa    relies    segments    launch    tests    least    imaging    lab    filed    treatment    reducing    true    revenues    sites    visco    clia    accordance    physicians    hematology    oncology    flow    maintenance    patient    direct    designed    portable    introduction    point    waiting    8kg    glucose    errors    affordable    85    run    forecasts    standard    time    belgium    efficient    vision    employees    analyser    sweden    waiver    care    fda    disposable    office    trials    72    outcomes    microfluidic    poc    elastic    safety    thousands    characterization    2022    operated    hydrodynamic    revolutionize    instead    cutting    medical    min    neonatal    classification    cell    ultimately    spread    transcription    blood    external    series    hemoscreen    chip    gold    market    patented    certification    cartridges    device    inefficiencies    36m    patent    2020    purchasing    containing    50    24    full    pixcell    uk    diagnostics    conduct    preliminary    improvement    requiring    500    calibration    performance    reduce    cytometry    trial    families    hours    minimizing    physician    uses    pol    labs   

Project "HemoScreen" data sheet

The following table provides information about the project.

Coordinator
PIXCELL MEDICAL TECHNOLOGIES LTD 

Organization address
address: 6 HAYEZIRA ST
city: YOKNEAM ILIT
postcode: 2069202
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Total cost 3˙556˙337 €
 EC max contribution 2˙489˙436 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2018
 Duration (year-month-day) from 2018-06-01   to  2020-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    PIXCELL MEDICAL TECHNOLOGIES LTD IL (YOKNEAM ILIT) coordinator 2˙489˙436.00

Map

 Project objective

HemoScreen is the first true point-of-care hematology analyser: a portable (8kg) and affordable (€4,500) device that can be operated by any medical personnel (no maintenance or calibration). The analyser uses low-cost (€8) disposable cartridges containing a high performance microfluidic chip. The phase 1 market study identified three priority segments for market introduction: physician office labs (POL), oncology and neonatal. In all 3 segments, HemoScreen can reduce the cost of the blood test by at least 50% as physicians can run the test with their own equipment instead of purchasing it from an external lab. More importantly, physicians can get immediate (9 min) results instead of waiting for 24-72 hours, cutting operational inefficiencies, reducing medical transcription errors, improving patient safety, minimizing the time to adequate treatment and ultimately, improving patient outcomes. HemoScreen relies on direct cell characterization based on imaging, the gold standard for cell classification, and a patented visco-elastic focusing method, which is more robust and efficient than hydrodynamic focusing (used in flow cytometry). The technology has already generated 7 patent families and 3 more are expected to be filed during this project. The project will conduct a series of trials involving over 4,000 blood tests over 5 trial sites spread between Sweden, Belgium, UK and USA. The trial results will be used for product improvement, industrialization and certification. Based on preliminary feedback from the FDA, the HemoScreen is the first true hematology POC analyser designed in accordance with CLIA waiver requirements, enabling thousands of physicians to run their own blood tests without requiring any lab certification. PixCell’s vision is to make cell-based diagnostics as simple as a glucose test and revolutionize POC diagnostics. Following a full market launch in 2020, PixCell medical forecasts revenues of €36M and headcount of 85 employees by 2022.

 Deliverables

List of deliverables.
Project website Websites, patent fillings, videos etc. 2020-01-16 15:53:22

Take a look to the deliverables list in detail:  detailed list of HemoScreen deliverables.

 Publications

year authors and title journal last update
List of publications.
2019 Anders Larsson
Hämatologi, ett laboratorieområde som kanske står inför stora förändringar
published pages: , ISSN: 1101-2013, DOI:
Nordisk Forening for Klinisk Kemi 2020-01-16
2019 Anders Larsson, Lena Carlsson, Bo Karlsson, Miklos Lipcsey
Rapid testing of red blood cell parameters in primary care patients using HemoScreenâ„¢ point of care instrument
published pages: , ISSN: 1471-2296, DOI: 10.1186/s12875-019-0971-2
BMC Family Practice 20/1 2020-01-16
2018 Anders Larsson, David Smekal, Miklos Lipcsey
Rapid testing of red blood cells, white blood cells and platelets in intensive care patients using the HemoScreenâ„¢ point-of-care analyzer
published pages: 1-4, ISSN: 0953-7104, DOI: 10.1080/09537104.2018.1557619
Platelets 2020-01-16
2018 Miklos Lipcsey, Johanna Helmersson-Karlqvist, Anders Larsson
Point of Care Testing of Red Blood Cells and Platelets in Intensive Care Patients Using HemoScreen
published pages: , ISSN: , DOI:
2020-01-16
2018 Miklos Lipcsey, Johanna Helmersson-Karlqvist, Anders Larsson
Rapid testing of red blood cells and platelets in intensive care patients using HemoScreenâ„¢ point of care instrument
published pages: , ISSN: , DOI:
2020-01-16

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HEMOSCREEN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "HEMOSCREEN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

MCBD (2019)

MCBD (MULTI-CORE BIOPSY DEVICE) INNOVATIVE BIOPSY TECHNOLOGY FOR THE NEW ERA OF TARGETED MEDICINE

Read More  

In-Heal (2019)

Standardised administration device for raw medical herbs

Read More  

Plasmanorg (2019)

Environmental-friendly organic chemical synthesis in plasma reactor

Read More